NG Biotech

NG Biotech is a French biotechnology company that develops and manufactures innovative rapid diagnostic tests for point-of-care use. The company is a global leader in the field of antimicrobial resistance (AMR), providing rapid multiplex lateral flow assays that can identify the five main types of carbapenemases in under 15 minutes. Their product portfolio also includes rapid tests for women's health, such as the first professional blood-based pregnancy test, and infectious diseases including COVID-19. NG Biotech operates with a strong focus on R&D, collaborating with organizations like the CEA to integrate advanced biotechnological tools into user-friendly formats. The company's manufacturing facilities are ISO 13485 certified, ensuring high-quality standards for clinical and laboratory settings worldwide.